The Collective Mid-Stage Exchange Fund

The Collective Mid-Stage Exchange Fund provides employees of selected private growth companies with valuations between $250mm and $600mm with a unique, tax-advantaged way to reduce their financial risk, gain liquidity and build long-term wealth

Mid-Stage Exchange Fund

Mid-Stage Exchange Fund Highlights

The Collective Mid-Stage Exchange Fund (the "Fund") portfolio is comprised primarily of venture-backed private companies with valuations between $250mm and $600mm.

To diversify and reduce their risk from being over concentrated in a single stock, employees may exchange their shares for a limited partnership in the Fund of equal value on a tax deferred basis.

To obtain liquidity after an initial holding period, Fund limited partners may choose to redeem some or all of their limited partnership interest for cash at the end of each quarter subject to certain limitations.

Number of Target Portfolio Companies Backed by Notable VCs

Diversification Strategy

The Collective Mid-Stage Exchange Fund seeks to reduce the risk of its limited partners by holding a diversified portfolio of private, venture-backed companies. Over time, the Fund will target a maximum allocation within its securities holdings of 30% in any industry sector and 10% to any individual company. To preserve the Fund's favorable tax treatment for exchangers under the U.S. tax code and enhance its diversification strategy, the Fund also holds approximately 20% of its assets in real estate investments. The Fund's real estate investments are generally professionally managed investment vehicles holding mature, stable properties diversified across type (e.g., residential, industrial, etc.) and across U.S. regions.

Mid-Stage Exchange Fund Targeted Exposure

75 %Unicorn Equity
20%Real Estate
5%Cash

How an Exchange Fund works

The Collective Mid-Stage Exchange Fund is a pooled investment vehicle enabling shareholders in selected private growth companies to contribute their shares into the Fund without triggering a capital gains tax. In return, they receive a limited partnership interest in the Fund of equal value. So, for every $100,000 worth of shares contributed into the Fund, the shareholder receives a $100,000 limited partnership in the Fund.

Exchange Fund - How it works
Learn more about the liquidity, diversification, tax savings and other benefits of our Exchange Funds

Portfolio Company Selection

Only shares of companies selected by Collective's Investment Committee may be exchanged into the Fund. Comprised of experienced, accomplished venture capitalists, the Committee first screens U.S. private growth companies valued at between $250mm and $600mm by a number of objective criteria including the backing of certain recognized venture capital firms. The Committee then reviews the remaining companies, selecting those that they believe to have the best risk adjusted opportunities for long-term valuation creation and that are expected to be sold or go public in the next 3-6 years. The list of these companies eligible for exchange into the Fund is continuously updated and is published on the Collective website.

customer representative 1
customer representative 2
customer representative 3

Questions?

Talk to a Collective Representative

Learn more - schedule a 15 minute call

Companies Eligible for Exchange into the Mid-Stage Fund

Many of the most successful VCs are invested in our Exchange Eligible Companies: Learn more

FogPharma's stock
Egenesis's stock
ReCode Therapeutics's stock
Infinitum's stock
Capstan Therapeutics's stock
Nalu Medical's stock
Arbor Biotechnologies's stock
Sionna's stock
Genesis Therapeutics's stock
Tomorrow.io's stock
LifeMine's stock
Dewpoint Therapeutics's stock
Synthekine's stock
Vizgen's stock
Ursa Major's stock
Chroma Medicine's stock
Heirloom's stock
Capella Space's stock
KSQ's stock
Frontier Medicines's stock
Alamar Biosciences's stock
Seismic Therapeutic's stock
Enfabrica's stock
Tome Biosciences's stock
IDRx's stock
Bluejay Therapeutics's stock
Every's stock
Triveni Bio's stock
Alterome Therapeutics's stock
MenloMicro's stock
Iambic Therapeutics's stock
Impulse Space's stock
TOCA Football's stock
Monarch Tractor's stock
Neuron23's stock
Jetty's stock
Gladly's stock
Primer's stock
A2 Bio's stock
Flare Therapeutics's stock
Cellanome's stock
Lycia Therapeutics's stock
Paradigm's stock
Detect's stock
Oishii's stock
Attralus's stock
Third Arc Bio's stock
Atmosic's stock
Engrail Therapeutics's stock
Pivotal Commware's stock
Outrider's stock
Viome Life Sciences's stock
Facet's stock
Marea's stock
Cowbell's stock
Vouch's stock
Hexagon Bio's stock
Harbinger's stock
AMP Smart Sortation's stock
Be Biopharma's stock
Check to see if your shares are eligible for exchange into our PortfolioBrowse all eligible companies
Learn more - schedule a 15 minute call

Fund Facts

Experienced Team

The Collective Late-Stage Exchange Fund is overseen by the Collective Investment Committee. The Committee is comprised of experienced venture capitalists and fund managers. The Committee is responsible for selecting companies for the Fund's portfolio and overseeing the Collective Private Market Valuation Algorithm which dynamically prices portfolio company shares.

Redemption

To provide its limited partners with liquidity, the Mid-Stage Exchange Fund permits redemptions of limited partnership interests at the end of each quarter for cash. After a three-year holding period, a limited partner may submit a redemption request for some or all of their interest in the Fund. Fund interests are redeemed at a purchase price implied by the Fund's Net Asset Value at the end of the quarter. The Fund's redemption obligations in any given quarter are limited to 4% of the Fund's aggregate Net Asset Value.

Fund Details

AdminSS&CAuditorCohn ReznikCustodianSchwab, PershingManagement Fee2%Performance Fee20%Minimum Investment$250,000LiquidityQuarterly redemptions at NAV after 3-year commitment subject to 4% of AUM gate

The Collective Valuation Algorithm

Collective's proprietary Private Market Valuation Algorithm dynamically prices shares of venture-backed, private growth companies and allocates exchange eligibility across the companies eligible for exchange into the Fund. The Fund relies on the algorithm for:

  • Valuing shares being exchanged into the Fund
  • Establishing loan-to-value ratios for loans secured by partnership interests
  • Determining the Fund's Net Asset Value
  • Valuing limited partnership interest for quarterly redemptions

The algorithm is designed to output real time valuations of private growth companies representative of the current market clearing price for their shares (as opposed to determining the company's value based on its future value based on fundamental analysis). As a result, the Fund's limited partners have transparency into the value of their capital accounts that is unique in the venture capital industry.

It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.Warren Buffet, Investor / Entrepreneur / Philanthropist
Learn more - schedule a 15 minute call

Risks of the Collective Mid-Stage Exchange Fund

Investments in portfolios of private growth companies are inherently risky and there are also potential risks specific to exchange funds. Some of these risks include:

  • Performance is not guaranteed. It is possible that the position(s) a shareholder contributed to the Fund will outperform the Fund's portfolio. The Fund may also fail to match the performance of the overall late-stage, private growth asset category.

  • Liquidity may be restricted. Though the Fund offers quarterly redemptions to its limited partners beginning on the first anniversary of their contribution, such redemptions are subject to restrictions in some circumstances. These restrictions are described in detail in the Fund's Private Placement Memorandum and other subscription documents.

  • Tax laws are subject to change. Although any change to the favorable treatment exchange funds receive would most likely be grandfathered in for current investors, it is possible that taxing authorities could elect to make such changes retroactive.

  • Fees can impact returns. The Exchange Fund charges annual management and performance fees, which can have a material impact on performance.

  • Real estate assets are included in the fund. Exchange funds generally need to invest at least 20% of fund assets in certain non-security investments—usually satisfied by purchasing real estate. These assets may adversely impact performance, increase risk and expose the fund to interest rate movements.

For a more complete description of these risks and a description of other risks related to an investment in the Collective Liquidity Fund, please review the Fund's Private Placement Memorandum, available for download from Collective Liquidity.

Collective unicorn companies

Disclosures

This information relating to the Collective Liquidity Fund, LP (the “Fund”) has been prepared solely for informational purposes, is not complete, and does not contain certain material information about the Fund, including important disclosures and risk factors associated with an investment in the Fund, and is subject to change without notice. It does not constitute an offer to buy or sell an interest in the Fund, nor shall there be any sale of a security in any jurisdiction where such solicitation or sale would be unlawful.

The Fund's limited partnership interest will not be registered with the U.S. Securities Exchange Commission or other regulatory authority. Investors will be required to verify their status as an “Accredited Investor” pursuant to Rule 501 of Regulation D to participate in any offering of the Fund’s limited partnership interests. No securities commission or regulatory authority has recommended or approved any investment or the accuracy or completeness of any of the information or materials provided by or through Collective Liquidity, Inc. or Collective Asset Management, LLC (collectively, “Collective Liquidity”).

Limited partnership interests in the Fund are not insured by the FDIC and are not deposits or other obligations of Collective Liquidity and are not guaranteed by Collective Liquidity. Limited partnership interests in the Fund are subject to investment risks, including possible loss of the principal invested..

Prospective investors should consider the investment objectives, risks, fees and expenses of the Fund carefully before investing in the Fund. This and other important information are contained in the Fund's Confidential Private Placement Memorandum (“PPM”), which can be obtained by contacting Collective Liquidity.

Investment in the Fund involves substantial risk and any offering may only be made pursuant to the relevant PPM and the relevant subscription application, all of which must be read in their entirety. No offer to purchase securities will be made or accepted prior to receipt by the offeree of these documents and the completion of all appropriate documentation. The Fund intends to primarily invest in securities of private, late-stage, venture-backed growth companies. There are significant potential risks relating to investing in such securities. The Fund is not suitable for investors who cannot bear the risk of loss of all or part of their investment. The Fund is appropriate only for investors who can tolerate a high degree of risk and do not require a liquid investment. The Fund has no history of public trading and investors should not expect to sell limited partnership interests in the Fund. No secondary market exists for the Fund's limited partnership interests, and none is expected to develop. The Exchange Fund has a limited operating history, and its performance is highly dependent upon the expertise and abilities of its manager. There is no assurance that the Exchange Fund's investment objectives will be achieved, and results may vary substantially over time. This is not a complete enumeration of the Fund's risks. Please read the Fund's PPM for other risk factors related to the Fund. Although the manager of the Exchange Fund will value its portfolio using the Private Market Valuation Algorithm, it can be difficult to obtain financial and other information with respect to private companies, and even where the manager is able to obtain such information, there can be no assurance that it is complete or accurate. Because such valuations are inherently uncertain and may be based on estimates, the manager's determinations of fair market value may differ materially from the values that would be assessed if a readily available market for these securities existed.

The information contained herein does not constitute a recommendation or advice by Collective Liquidity. You should consult your own tax, legal, accounting, financial or other advisers about the information discussed herein based on your specific risk profile and financial situation, including the suitability of an investment in the Fund, with Collective Liquidity, or any product managed by Collective Liquidity.

The information contained herein is for informational purposes only. This material contains the current opinions of Collective Liquidity and such opinions are subject to change without notice. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission.

Own unicorn shares or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure